Werfen

Founded in 1966 in Barcelona, Werfen is a global leader in specialized diagnostics dedicated to advancing patient care through innovation and excellence. The company develops, manufactures, and distributes instruments, reagents, and data management solutions for Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant testing.

Privately held and family-owned, Werfen operates directly in more than 30 countries and through distributors in over 100 markets worldwide, with major technology centers in Europe and the United States. Its products and systems are trusted by hospitals and laboratories globally to deliver accurate, efficient, and reliable diagnostic results that enhance clinical decision-making and patient outcomes.

With annual revenues exceeding €2 billion and a workforce of approximately 7,000 employees, Werfen continues to strengthen its leadership through research, strategic acquisitions, and a steadfast commitment to quality, integrity, and customer focus.

Driven by the purpose of “contributing to the advancement of patient care around the world through innovative Specialized Diagnostics,” Werfen remains at the forefront of scientific progress—offering high-value solutions that empower healthcare professionals and improve lives.